Fenofibrate Nanocrystalize
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- SPE2D220R0073
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation from the Defense Logistics Agency Troop Support Medical seeks nanocrystallized fenofibrate tablets meeting specifications provided. Vendors must supply fenofibrate in a tablet form that has been nanocrystallized to meet the agency's medical requirements. Proposals were due by October 23, 2020, with evaluation criteria including technical qualifications, past performance, and price factors. An amendment on October 7, 2020 provided additional details.
There is no set-aside designation. The primary NAICS is 325412 with PSC 6515 as the product service code. The incumbent contractor was Golden State Medical Supply Inc. under contract SPE2D2-21-D-0131, which was terminated for convenience in January 2024 after supplying approximately 2 million tablets annually from 2021 through 2023. The performance location was the contractor's facility. This concludes the summary.
Notice text
5 versions
Update #5 · Latest ·
Modification P00004 SPE2D2-21-D-0131 No Cost-Settlement Termination for Convenience.
Modification P00003 SPE2D2-21-D-0131 to incorporate FAR Claluse 52.204-27 Prohibition on a Bytedance Covered Application (JUN 2023) into contract.
Option Year 2 P00002 SPE2D2-21-D-0131 to invoke option period of April 05, 2023 through April 04, 2024.
Option Year 1 P00001 SPE2D2-21-D-0131 to invoke option period of April 05, 2022 through April 04, 2023.
Amendment 0001 is issued to extend the closing date until October 23, 2020 at 3:00 PM EDT.
Solicitation for Fenofibrate Nanocrystalize Tablets SPE2D2-20-R-0073.
Update #4 ·
Option Year 2 P00002 SPE2D2-21-D-0131 to invoke option period of April 05, 2023 through April 04, 2024.
Option Year 1 P00001 SPE2D2-21-D-0131 to invoke option period of April 05, 2022 through April 04, 2023.
Amendment 0001 is issued to extend the closing date until October 23, 2020 at 3:00 PM EDT.
Solicitation for Fenofibrate Nanocrystalize Tablets SPE2D2-20-R-0073.
Update #3 ·
Option Year 1 P00001 SPE2D2-21-D-0131 to invoke option period of April 05, 2022 through April 04, 2023.
Amendment 0001 is issued to extend the closing date until October 23, 2020 at 3:00 PM EDT.
Solicitation for Fenofibrate Nanocrystalize Tablets SPE2D2-20-R-0073.
Update #2 ·
Amendment 0001 is issued to extend the closing date until October 23, 2020 at 3:00 PM EDT.
Solicitation for Fenofibrate Nanocrystalize Tablets SPE2D2-20-R-0073.
Update #1 ·
Solicitation for Fenofibrate Nanocrystalize Tablets SPE2D2-20-R-0073.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| Fenofibrate Nanocrystalize | Award Notice | |
| This notice | Solicitation | |
| Fenofibrate Nanocrystalize | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity